EichorEICHOR
Condition: Haemophilus Influenzae Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Haemophilus Influenzae

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalen
Phase 2/Phase 3 · 1 location(s) · LG Chem · NCT06947499Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NA · 1 location(s) · Jiangsu Province Centers for Disease Control and Prevention · NCT06605755Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135
Phase 1 · 1 location(s) · CanSino Biologics Inc. · NCT07203755National Bacterial Meningitis Study in Children and Newborns
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04664569
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.